These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12198619)

  • 1. Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation.
    Cortez K; Murphy BR; Almeida KN; Beeler J; Levandowski RA; Gill VJ; Childs RW; Barrett AJ; Smolskis M; Bennett JE
    J Infect Dis; 2002 Sep; 186(6):834-8. PubMed ID: 12198619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Hemming VG
    Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
    DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
    Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin.
    Siber GR; Leombruno D; Leszczynski J; McIver J; Bodkin D; Gonin R; Thompson CM; Walsh EE; Piedra PA; Hemming VG
    J Infect Dis; 1994 Jun; 169(6):1368-73. PubMed ID: 8195619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model.
    Ottolini MG; Porter DD; Hemming VG; Zimmerman MN; Schwab NM; Prince GA
    Bone Marrow Transplant; 1999 Jul; 24(1):41-5. PubMed ID: 10435733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoprophylaxis of group B respiratory syncytial virus infection in cotton rats.
    Faverio LA; Piazza FM; Johnson SA; Darnell ME; Ottolini MG; Hemming VG; Prince GA
    J Infect Dis; 1997 Apr; 175(4):932-4. PubMed ID: 9086152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.
    Langley JM; Sales V; McGeer A; Guasparini R; Predy G; Meekison W; Li M; Capellan J; Wang E
    Vaccine; 2009 Sep; 27(42):5913-9. PubMed ID: 19651171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats.
    Sami IR; Piazza FM; Johnson SA; Darnell ME; Ottolini MG; Hemming VG; Prince GA
    J Infect Dis; 1995 Feb; 171(2):440-3. PubMed ID: 7844385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.
    Walsh EE; Falsey AR
    J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
    Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
    Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk children.
    Groothuis JR
    J Pediatr; 1994 May; 124(5 Pt 2):S28-32. PubMed ID: 8169755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin.
    Graham BS; Tang YW; Gruber WC
    J Infect Dis; 1995 Jun; 171(6):1468-74. PubMed ID: 7769280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus.
    Hancock GE; Smith JD; Heers KM
    J Infect Dis; 2000 May; 181(5):1768-71. PubMed ID: 10823781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.
    Valosky J; Hishiki H; Zaoutis TE; Coffin SE
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):171-9. PubMed ID: 15643003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children.
    Simoes EA; Groothuis JR; Tristram DA; Allessi K; Lehr MV; Siber GR; Welliver RC
    J Pediatr; 1996 Aug; 129(2):214-9. PubMed ID: 8765618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
    Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization.
    Wu H; Pfarr DS; Tang Y; An LL; Patel NK; Watkins JD; Huse WD; Kiener PA; Young JF
    J Mol Biol; 2005 Jul; 350(1):126-44. PubMed ID: 15907931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
    Zeng RH; Gong W; Fang XP; Zhang ZY; Mei XG
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):534-9. PubMed ID: 16176088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.